Scimitar Equity Research, Inc. Initiates ''BUY'' Stock Ranking of Neurobiological Technologies, Inc.Business Editors BOSTON--(BUSINESS WIRE)--April 13, 2004 Scimitar Equity Research, Inc. (Scimitar) today announced the initiation of a "BUY" stock ranking of Neurobiological neu·ro·bi·ol·o·gy n. The biological study of the nervous system or any part of it. neu  ro·bi Technologies, Inc. (NTII NTII Neurobiological Technologies, Inc. ). The analyst research review entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: "The Neuroprotection The term neuroprotection refers to mechanisms within the nervous system which protect neurons from apoptosis or degeneration, for example following a brain injury or as a result of chronic neurodegenerative diseases. Opportunity... Expanding the Definition of Innovation" is available on Scimitar's website; www.scimitarequity.com. Scimitar Equity Research, Inc. provides independent, objective research and analysis of the health science industry for the institutional and investment communities. Scimitar integrates scientific and financial analysis to identify those companies demonstrating real progress towards their vision while meeting quarterly expectation. Scimitar does not own any securities or accept payment of fees in company stock related to the companies we provide analysis or develop research products. We do not have investment banking relationships with any company to maintain our independence and objectivity. Investors are advised that this analysis and review is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual of an offer to buy. Scimitar was paid for continuing coverage and preparing this research review. Please read all our important disclosures including Compensation for Products and Services at www.scimitarequity.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion